Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDECABTAGENE VICLEUCEL for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where IDECABTAGENE VICLEUCEL was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for IDECABTAGENE VICLEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 607 58.5% 57 253
Immune effector cell-associated neurotoxicity syndrome 176 17.0% 30 72
Fatigue 159 15.3% 2 4
Neurotoxicity 70 6.8% 11 36
Neutropenia 68 6.6% 6 17
Pyrexia 67 6.5% 0 32
Anaemia 63 6.1% 2 8
Decreased appetite 54 5.2% 1 2
Headache 54 5.2% 0 3
Hypogammaglobulinaemia 54 5.2% 7 19
Nausea 54 5.2% 0 3
Aspartate aminotransferase increased 48 4.6% 1 0
Death 47 4.5% 47 6
Diarrhoea 44 4.2% 1 1
Hypotension 43 4.2% 2 9

Other Indications for IDECABTAGENE VICLEUCEL

Plasma cell myeloma (737) Plasma cell myeloma refractory (155) Product used for unknown indication (74) Plasma cell leukaemia (5)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

IDECABTAGENE VICLEUCEL Full Profile All Diffuse large b-cell lymphoma Drugs IDECABTAGENE VICLEUCEL Demographics IDECABTAGENE VICLEUCEL Timeline